Early Career Psychiatrists Programme
This symposium aims to provide a comprehensive exploration of the information technologies in psychiatry intersection. Focusing on the future needs of early career psychiatrists, the symposium will explore the impact of digital technologies on the mental health field. Attendees will gain a deeper understanding of how to harness these innovations in their everyday practice while considering the ethical, political, and societal implications. Moreover, the symposium will delve into the relevance of emerging virtual environments, highlighting the importance of remaining at the forefront of technological advancements in patient care. Through this symposium, we aim to shape the future of mental health, fostering a technologically adept, ethically aware generation of psychiatrists.
Chair: Dr Egor Chumakov, Russia
Co-Chair: Dr Livia De Picker, Belgium
Exploring the Metaverse: Implications for Psychiatry from a Neuroscience and Neuroethics Perspective
Speaker: Prof. Donatella Marazziti, Italy
The Ethical Aspects of Information Technologies in Psychiatry: what early career psychiatrists will encounter in their work
Speaker: Prof. Meryam Schouler-Ocak, Germany
Navigating Information Technologies in Everyday Psychiatry Practice: A Guide for Early Career Psychiatrists
Speaker: Dr Kirill Vasilchenko, Israel
Integrating Digital Psychiatry into Medical Training Curricula
Speaker: Dr Anna Bailie, UK
This symposium will focus on the theoretical and practical aspects of the use of compulsory measures in psychiatry and the use of ECT, two very sensitive topics in psychiatry. International recommendations for reducing coercion in psychiatry will be reviewed, and the challenges that early career psychiatrists encounter in their work with compulsory treatment and how to address them will be described. The symposium will continue with the topic of ECT use in clinical practice from the perspective of early career psychiatrists, and will present the results of an international survey of trainee experiences and attitudes towards ECT. The symposium will conclude with a description of the experiences of ECT Accreditation Services in the UK. As a result of the symposium, participants will improve their knowledge of ethical and practical skills in relation to reducing coercion in psychiatry, as well as expanding their knowledge of the ethical and practical aspects of ECT use.
Chair: Prof. Danuta Wasserman, Sweden
Co-Chair: Dr Egor Chumakov, Russia
Alternatives to coercion
Speaker: Prof. Meryam Schouler-Ocak, Germany
Challenges that early career psychiatrists can face on compulsory treatment
Speaker: Dr Egor Chumakov, Russia
Trainees experiences and attitudes towards ECT – an international study
Speaker: Dr Cristiana Tapoi, Romania
The UK experience and the RCPsych ECT Accreditation Services
Speaker: Dr Mariana Pinto da Costa, UK
In this session Prof. Sartorius will recapitulate the historical evolvement of user involvement while Prof. Judit Balasz and Dr Howard Ryland will provide practical insight on digital implications in youth and forensic psychiatry.
Chair: Dr Asilay Seker, UK
Co-Chair: Prof. Danuta Wasserman, Sweden
User involvement in youth mental health
Speaker: Prof. Judit Balazs , Hungary
Public & patient involvement: then and now
Speaker: Prof. Norman Sartorius, Switzerland
User involvement in forensic psychiatry
Speaker: Dr Howard Ryland, UK
User involvement in psychiatric research: shifting from traditional research paradigms to collaborative partnerships
Speaker: Dr Daniele Cavaleri, Italy
This symposium aims at providing insights for understanding, discussing, and unraveling the labyrinth of diagnostic challenges in autism spectrum disorders (ASD) in 2023. Hot topics such as the differential manifestations of Autism Spectrum Disorder (ASD) between genders and the intricate intersections as well as distinctions between autism and Attention Deficit Hyperactivity Disorder (ADHD) will be dissected. Other prominent areas of focus will encompass the intricate relationship between autism and eating disorders and the pivotal role of genetic counseling in autism, offering a comprehensive analysis of the complex diagnostic landscape of ASD.
Chair: Dr Tomasz Gondek , Poland
Co-Chair: Dr Iris Manor, Israel
Autism and sex differences: implications on diagnostic instruments
Speaker: Dr Asilay Seker, UK
Autism and ADHD
Speaker: Dr Federico Mucci, Italy
Unpicking autism and eating disorders
Speaker: Dr Mima Simic, UK
The interface between immunology and autism
Speaker: Dr Marion Leboyer, France
In this session, we will present and discuss the Cutting Edge Innovation in Mental Health Research and Clinical Trials. Prof. Richard Emsley from King’s College London will delve into the potential of clinical trials to accelerate the process of answering treatment-related questions while minimizing participant numbers, discovering how innovative methodologies can enhance efficiency and expedite advancements in mental health treatments. Prof. Inez Myin-Germeys from the University of Leuven, Belgium, will explore the intriguing realm of Ecological Momentary Assessments (EMA) and their applicability in investigating person-environment interactions among individuals with psychosis, and share her expertise into how EMA can unveil dynamic insights into the complex interplay between individuals and their surroundings. Prof. Robert Stewart, from King’s College London, will shed light on the use of electronic health records as a tool for clinical trials, leading to more efficient and comprehensive clinical research practices.
Chair: Dr Mariana Pinto da Costa, Portugal/UK
Co-Chair: Dr Tomasz Gondek, Poland
How can clinical trials expedite the process of answering treatment-related questions and reduce the number of participants needed?
Speaker: Prof. Richard Emsley, UK
Can Ecological Momentary assessments be used to investigate the person-environment interactions in people with psychosis?
Speaker: Prof. Inez Myin-Germeys, Belgium
How can electronic health records serve as a tool for clinical trials?
Speaker: Prof. Robert Stewart, UK
What are the ethical considerations for conducting responsible AI Research?
Speaker: Dr Mariana Pinto da Costa, Portugal/UK
Stigma, the pervasive devaluation and marginalization of people with mental illnesses, has become a matter of major concern from a public health perspective and it represents also a practical obstacle for health providers involved in the care of people with severe mental disorders. It is an even larger issue for people who have a mental illness and their family members, who also experience stigma directly and by association. In this symposium, experts in the field will discuss the most recent strategies developed for challenging stigma as well as they will delineate the possible role of ECPs in overcoming stigma.
Chair: Prof. Norman Sartorius, Switzerland
Co-Chair: Prof. Gaia Sampogna, Italy
The complexity of stigma in the modern society and its impact on people with severe mental disorders
Speaker: Prof. Norman Sartorius, Switzerland
What can scientific associations do for ending stigma of mental illness
Speaker: Prof. Petr Winkler, Czech Republic
Strategies and initiatives by early career psychiatrists for ending stigma of mental disorders
Speaker:Anna Szczegielniak, Poland
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder. It is frequently comorbid with other mental disorders and may significantly affect global functioning. Despite its widespread occurrence in adults, many general psychiatrists do not feel well prepared to diagnose and manage this disorder. Psychiatry training curricula rarely include rotations in specialized ADHD clinics for adults or specialized courses during residency, and in many European countries such specialized clinics for adults, or the most recommended medications, are not even available. It makes the recognition and treatment of ADHD often overlooked, unless it has been diagnosed in childhood. The aim of the educational workshop dedicated to Early Career Psychiatrists is to equip clinicians with practical knowledge on how to understand the course of this disorder and manage patients with ADHD symptoms. The speakers will address the areas signalled as the most important by the ECPs, from ADHD pathophysiology, through diagnostic instruments in adults, differential diagnosis, psychoeducation and treatment options. The speakers specialize in the field of ADHD in clinical practice or research in different countries and will be ready to lead an interactive discourse with the audience, focused on the most practical competencies for psychiatrists early in their career.
Chair: Dr Ozge Kilic, Türkiye
Co-Chair: Dr Anna Szczegielniak, Poland
Comorbid sleep problems in ADHD
Speaker: Prof. Dora Wynchank , Netherlands
Principles of ADHD diagnosis in adults
Speaker: Dr Agata Todzia-Kornaś, Poland
Females with ADHD
Speaker: Dr Ozge Kilic, Türkiye
Pharmacological management of ADHD in adults
Speaker: Dr. Tomasz Gondek, Poland
This debate is about different drug classification systems: the novel Neuroscience based Nomenclature and the widely known WHO-endorsed ATC indication based classification.
Judge: Prof. Donatella Marazziti , Italy
Chair: Dr Asilay Seker, UK
Co-Chair: Dr Daniele Cavaleri, Italy
NbN
Speaker: Prof. Joseph Zohar, Israel
ATC
Speaker: Prof. Pavel Mohr, Czech Republic
This debate session aims at exploring the potential multifaceted relationships amongst artificial intelligence (AI), metaverse and psychiatry. Two experts will discuss the potential benefits and challenges AI and metaverse present for psychiatry, from improved diagnostics and personalized treatments to ethical considerations and job displacement, in the attempt of fostering a comprehensive understanding of AI and metaverse positions in the future of psychiatry.
Judge: Dr Asilay Seker, UK
Chair: Dr Federico Mucci, Italy
Co-Chair: Dr Egor Chumakov, Russia
Pro to AI/metaverse implementation
Speaker: Prof. Leonardo Fontenelle, Brazil
Con to AI/metaverse implementation
Speaker: Dr Anna Bailie, UK